21.65
전일 마감가:
$22.43
열려 있는:
$22.19
하루 거래량:
2.52M
Relative Volume:
0.99
시가총액:
$2.79B
수익:
$642.82M
순이익/손실:
$-43.54M
주가수익비율:
-61.93
EPS:
-0.3496
순현금흐름:
$130.12M
1주 성능:
-2.83%
1개월 성능:
-3.05%
6개월 성능:
+62.05%
1년 성능:
+156.82%
10X 제노믹스 Stock (TXG) Company Profile
명칭
10 X Genomics Inc
전화
(925) 401-7300
주소
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, BTSG, TEM, HQY, DOCS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
TXG
10 X Genomics Inc
|
21.65 | 2.89B | 642.82M | -43.54M | 130.12M | -0.3496 |
|
VEEV
Veeva Systems Inc
|
170.22 | 28.03B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
53.54 | 10.16B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
55.81 | 9.87B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
HQY
Healthequity Inc
|
82.18 | 6.96B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
DOCS
Doximity Inc
|
24.89 | 4.61B | 637.78M | 239.40M | 307.21M | 1.1909 |
10X 제노믹스 Stock (TXG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-31 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-12-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | 개시 | Piper Sandler | Neutral |
| 2025-02-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | 개시 | Leerink Partners | Outperform |
| 2024-07-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-07-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-10 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-06-27 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-05-01 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-12-12 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-10 | 개시 | Barclays | Overweight |
| 2023-03-31 | 개시 | Stephens | Overweight |
| 2023-02-02 | 개시 | UBS | Neutral |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-08-18 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-07-25 | 개시 | Canaccord Genuity | Buy |
| 2022-07-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-09-14 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-03-15 | 개시 | William Blair | Outperform |
| 2020-12-02 | 개시 | Goldman | Neutral |
| 2020-09-09 | 개시 | Morgan Stanley | Overweight |
| 2020-07-10 | 개시 | Stifel | Buy |
| 2020-03-05 | 개시 | Guggenheim | Buy |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-10-07 | 개시 | BofA/Merrill | Buy |
| 2019-10-07 | 개시 | Cowen | Outperform |
| 2019-10-07 | 개시 | JP Morgan | Overweight |
| 2019-09-24 | 개시 | Evercore ISI | Outperform |
모두보기
10X 제노믹스 주식(TXG)의 최신 뉴스
MSN Money - MSN
10x Genomics (TXG) price target increased by 12.41% to 23.75 - MSN
M&T Bank Corp Has $1.19 Million Stake in 10x Genomics $TXG - MarketBeat
10x Genomics (TXG) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
10x Genomics Inc (HAM:1KJ) Dividend - GuruFocus
TXG Price Today: 10x Genomics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
10X Genomics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock Price, Trades & News - GuruFocus
Q3 2025 10X Genomics Inc Earnings Call Transcript - GuruFocus
10x Genomics Inc Stock Intrinsic Values | HAM:1KJ - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
10x Genomics Inc Stock Warning Signs | HAM:1KJ - GuruFocus
10x Genomics Inc Stock Operating Data - GuruFocus
10x Genomics Inc (HAM:1KJ) Valuation: Fairly Valued - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock Price & 30 Year Financial Data - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock Earnings Transcripts - GuruFocus
10x Genomics Inc (HAM:1KJ) Competitors 2026 - GuruFocus
10x Genomics Inc (HAM:1KJ) DCF Valuation - GuruFocus
10x Genomics Inc (HAM:1KJ)Valuation Measures & Financial Statistics - GuruFocus
10x Genomics Inc (HAM:1KJ) Stock News, Headlines & Updates - GuruFocus
TXG Stock Chart | 10X GENOMICS INC-CLASS A (NASDAQ:TXG) - ChartMill
Vanguard holds 6.17M shares of 10X Genomics (NASDAQ: TXG), 5.24% stake - Stock Titan
10x Genomics investors can watch management at a May 13 BofA chat - Stock Titan
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference - Barchart.com
10x Genomics (NASDAQ:TXG) Trading Down 8%What's Next? - MarketBeat
10x Genomics joins a 100,000-patient tissue atlas across 3 continents - Stock Titan
TXG Stock Price, Quote & Chart | 10X GENOMICS INC-CLASS A (NASDAQ:TXG) - ChartMill
Vanguard Portfolio Management reports 6.98M TXG shares (NASDAQ: TXG) - Stock Titan
10x Genomics seen as key player in AI-driven biological data buildout - MSN
10x Genomics (TXG) details 2026 virtual meeting, director votes and Say on Pay - Stock Titan
Why 10x Genomics (TXG) Shares Are Trading Lower Today - Yahoo Finance
10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - MSN
TXG Financials: Income Statement, Balance Sheet & Cash Flow | 10X Genomics, Inc. - Stock Titan
10X Genomics Hits New 52-Week High at $25.69, Showcasing Market Resilience - Markets Mojo
10X Genomics Experiences Evaluation Revision Amid Strong Market Performance and Volatility - Markets Mojo
10x Genomics introduces Atera at AACR 2026 - SelectScience
10X Genomics Hits New 52-Week High of $26.44, Reflecting Strong Growth - Markets Mojo
10x Genomics (NASDAQ:TXG) Reaches New 1-Year HighHere's What Happened - MarketBeat
10x Genomics Stock Up on Atera Launch, Spatial Biology Scale Enhanced - Yahoo Finance
Bayforest Capital Ltd Has $286,000 Holdings in 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
10x Genomics (TXG) Launches Atera: A Breakthrough in Spatial Bio - GuruFocus
10x Genomics, Inc.Common Stock (NQ: TXG - The Chronicle-Journal
10x Genomics Launches Atera Platform for Spatial Biology - Intellectia AI
10x opens Atera pre-orders for cell-by-cell mapping across whole tissues - Stock Titan
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood - ChartMill
10X Genomics Opens with 6.32% Gain, Outperforming S&P 500's 2.51% Increase - Markets Mojo
Best Genomics Stocks for 2026 and How to Invest - The Motley Fool
10X 제노믹스 (TXG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):